OvaScience (NASDAQ:OVAS) will be issuing its quarterly earnings data after the market closes on Thursday, March 15th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter.
OvaScience (OVAS) opened at $1.06 on Tuesday. OvaScience has a 12 month low of $0.90 and a 12 month high of $2.05. The stock has a market capitalization of $36.42, a P/E ratio of -0.58 and a beta of 3.05.
Separately, Zacks Investment Research downgraded OvaScience from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th.
OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company’s portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient’s own ovarian tissue.
Receive News & Ratings for OvaScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OvaScience and related companies with MarketBeat.com's FREE daily email newsletter.